The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
The global Dengue Virus Diagnostic Tests market was valued at US$ 3250.3 million in 2023 and is anticipated to reach US$ 4188 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dengue Virus Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Virus Diagnostic Tests.
Report Scope
The Dengue Virus Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dengue Virus Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Virus Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Alere
- Biogate
- NovaBios Laboratories Diagnostics
- Rapikit
- Wondfo
- BTNX
- GENESIS
- Boson Biotech
- Adaltis
- AccuBio Tech
- Mediven
- NTBIO
Segment by Type
- Dengue NS1Ag Test
- Dengue IgG/IgM Test
- Dengue NS1 Ag-IgG/IgM Test
Segment by Application
- Hospital
- Research Institution
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dengue Virus Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dengue Virus Diagnostic Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dengue NS1Ag Test
1.2.3 Dengue IgG/IgM Test
1.2.4 Dengue NS1 Ag-IgG/IgM Test
1.3 Market by Application
1.3.1 Global Dengue Virus Diagnostic Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dengue Virus Diagnostic Tests Market Perspective (2019-2030)
2.2 Dengue Virus Diagnostic Tests Growth Trends by Region
2.2.1 Global Dengue Virus Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dengue Virus Diagnostic Tests Historic Market Size by Region (2019-2024)
2.2.3 Dengue Virus Diagnostic Tests Forecasted Market Size by Region (2025-2030)
2.3 Dengue Virus Diagnostic Tests Market Dynamics
2.3.1 Dengue Virus Diagnostic Tests Industry Trends
2.3.2 Dengue Virus Diagnostic Tests Market Drivers
2.3.3 Dengue Virus Diagnostic Tests Market Challenges
2.3.4 Dengue Virus Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dengue Virus Diagnostic Tests Players by Revenue
3.1.1 Global Top Dengue Virus Diagnostic Tests Players by Revenue (2019-2024)
3.1.2 Global Dengue Virus Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Dengue Virus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dengue Virus Diagnostic Tests Revenue
3.4 Global Dengue Virus Diagnostic Tests Market Concentration Ratio
3.4.1 Global Dengue Virus Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dengue Virus Diagnostic Tests Revenue in 2023
3.5 Dengue Virus Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Dengue Virus Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Dengue Virus Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dengue Virus Diagnostic Tests Breakdown Data by Type
4.1 Global Dengue Virus Diagnostic Tests Historic Market Size by Type (2019-2024)
4.2 Global Dengue Virus Diagnostic Tests Forecasted Market Size by Type (2025-2030)
5 Dengue Virus Diagnostic Tests Breakdown Data by Application
5.1 Global Dengue Virus Diagnostic Tests Historic Market Size by Application (2019-2024)
5.2 Global Dengue Virus Diagnostic Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dengue Virus Diagnostic Tests Market Size (2019-2030)
6.2 North America Dengue Virus Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dengue Virus Diagnostic Tests Market Size by Country (2019-2024)
6.4 North America Dengue Virus Diagnostic Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dengue Virus Diagnostic Tests Market Size (2019-2030)
7.2 Europe Dengue Virus Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dengue Virus Diagnostic Tests Market Size by Country (2019-2024)
7.4 Europe Dengue Virus Diagnostic Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dengue Virus Diagnostic Tests Market Size (2019-2030)
8.2 Asia-Pacific Dengue Virus Diagnostic Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dengue Virus Diagnostic Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Dengue Virus Diagnostic Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dengue Virus Diagnostic Tests Market Size (2019-2030)
9.2 Latin America Dengue Virus Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dengue Virus Diagnostic Tests Market Size by Country (2019-2024)
9.4 Latin America Dengue Virus Diagnostic Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dengue Virus Diagnostic Tests Market Size (2019-2030)
10.2 Middle East & Africa Dengue Virus Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dengue Virus Diagnostic Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Dengue Virus Diagnostic Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Dengue Virus Diagnostic Tests Introduction
11.1.4 Alere Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.1.5 Alere Recent Development
11.2 Biogate
11.2.1 Biogate Company Detail
11.2.2 Biogate Business Overview
11.2.3 Biogate Dengue Virus Diagnostic Tests Introduction
11.2.4 Biogate Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.2.5 Biogate Recent Development
11.3 NovaBios Laboratories Diagnostics
11.3.1 NovaBios Laboratories Diagnostics Company Detail
11.3.2 NovaBios Laboratories Diagnostics Business Overview
11.3.3 NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Introduction
11.3.4 NovaBios Laboratories Diagnostics Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.3.5 NovaBios Laboratories Diagnostics Recent Development
11.4 Rapikit
11.4.1 Rapikit Company Detail
11.4.2 Rapikit Business Overview
11.4.3 Rapikit Dengue Virus Diagnostic Tests Introduction
11.4.4 Rapikit Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.4.5 Rapikit Recent Development
11.5 Wondfo
11.5.1 Wondfo Company Detail
11.5.2 Wondfo Business Overview
11.5.3 Wondfo Dengue Virus Diagnostic Tests Introduction
11.5.4 Wondfo Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.5.5 Wondfo Recent Development
11.6 BTNX
11.6.1 BTNX Company Detail
11.6.2 BTNX Business Overview
11.6.3 BTNX Dengue Virus Diagnostic Tests Introduction
11.6.4 BTNX Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.6.5 BTNX Recent Development
11.7 GENESIS
11.7.1 GENESIS Company Detail
11.7.2 GENESIS Business Overview
11.7.3 GENESIS Dengue Virus Diagnostic Tests Introduction
11.7.4 GENESIS Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.7.5 GENESIS Recent Development
11.8 Boson Biotech
11.8.1 Boson Biotech Company Detail
11.8.2 Boson Biotech Business Overview
11.8.3 Boson Biotech Dengue Virus Diagnostic Tests Introduction
11.8.4 Boson Biotech Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.8.5 Boson Biotech Recent Development
11.9 Adaltis
11.9.1 Adaltis Company Detail
11.9.2 Adaltis Business Overview
11.9.3 Adaltis Dengue Virus Diagnostic Tests Introduction
11.9.4 Adaltis Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.9.5 Adaltis Recent Development
11.10 AccuBio Tech
11.10.1 AccuBio Tech Company Detail
11.10.2 AccuBio Tech Business Overview
11.10.3 AccuBio Tech Dengue Virus Diagnostic Tests Introduction
11.10.4 AccuBio Tech Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.10.5 AccuBio Tech Recent Development
11.11 Mediven
11.11.1 Mediven Company Detail
11.11.2 Mediven Business Overview
11.11.3 Mediven Dengue Virus Diagnostic Tests Introduction
11.11.4 Mediven Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.11.5 Mediven Recent Development
11.12 NTBIO
11.12.1 NTBIO Company Detail
11.12.2 NTBIO Business Overview
11.12.3 NTBIO Dengue Virus Diagnostic Tests Introduction
11.12.4 NTBIO Revenue in Dengue Virus Diagnostic Tests Business (2019-2024)
11.12.5 NTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
